RAQUEL MEJOS: Open Payments
NPI 1114516754 · ANTIOCH, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 17 payments from 8 companies in 2025. Trend: 2023 $408 · 2024 $416 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $135 |
| ABBVIE INC. | 2 | $67 |
| Lilly USA, LLC | 3 | $51 |
| Exact Sciences Corporation | 2 | $48 |
| Astellas Pharma US Inc | 2 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: UBRELVY, MOUNJARO, Veozah, Wegovy, ZENPEP, Cologuard Collection Kit, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across IL — which companies pay providers there.
